IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Reader Login
Users Online : 1973 
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2020| September-October  | Volume 52 | Issue 5  
    Online since December 5, 2020

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
CLINICAL RESEARCH ARTICLES
To study impact of treatment with Rosuvastatin versus Atorvastatin on 25 hydroxy Vitamin D concentrations among adult Indian men- a randomized control trial
Vivek G Patwardhan, Zulf M Mughal, Raja Padidela, Shashi A Chiplonkar, Vaman V Khadilkar, Anuradha V Khadilkar
September-October 2020, 52(5):365-371
DOI:10.4103/ijp.IJP_93_18  
  3,963 170 -
Efficacy and safety of 7 days versus 10 days triple therapy based on levofloxacin-dexlansoprazole for eradication of Helicobacter pylori: A pilot randomized trial
Noha Mahmoud Elkhodary, Khaled Abdalkader Farrag, Amany Mahmoud Elokaby, Gamal Abd El-Hay Omran
September-October 2020, 52(5):356-364
DOI:10.4103/ijp.IJP_364_19  
  3,606 132 -
EDITORIAL
Novel therapeutic approaches toward Hantaan virus and its clinical features’ similarity with COVID-19
Harvinder Singh, Harpinder Kaur, Bikash Medhi
September-October 2020, 52(5):347-355
DOI:10.4103/ijp.ijp_1001_20  
  3,565 136 -
SYSTEMATIC REVIEW
Systematic review and meta-analysis of effectiveness and safety of favipiravir in the management of novel coronavirus (COVID-19) patients
Ajay Prakash, Harvinder Singh, Hardeep Kaur, Ankita Semwal, Phulen Sarma, Anusuya Bhattacharyya, Deba Prasad Dhibar, Bikash Medhi
September-October 2020, 52(5):414-421
DOI:10.4103/ijp.ijp_998_20  
  2,182 64 -
REVIEW ARTICLE
Antibody–drug conjugates, cancer immunotherapy, and metronomic chemotherapy as novel approaches in cancer management
Sudhir Chandra Sarangi, Pranav Sopory, Soumya Sucharita Pattnaik, KH Reeta
September-October 2020, 52(5):402-413
DOI:10.4103/ijp.IJP_475_18  
  1,312 73 -
EDUCATIONAL FORUM
Organoids: An invaluable tool in pharmacology
Sadasivam Balakrishnan, Shubham Atal, Avik Ray, CA Pravin, Malaya Nanda
September-October 2020, 52(5):422-429
DOI:10.4103/ijp.IJP_137_19  
  1,238 72 -
EXPERIMENTAL RESEARCH ARTICLE
Human adipose-derived stem cells reduce receptor-interacting protein 1, receptor-interacting protein 3, and mixed lineage kinase domain-like pseudokinase as necroptotic markers in rat model of Alzheimer’s disease
Mina Eftekharzadeh, Sara Simorgh, Maryam Doshmanziari, Leila Hassanzadeh, Marjan Shariatpanahi
September-October 2020, 52(5):392-401
DOI:10.4103/ijp.IJP_545_19  
  1,056 41 -
Low oxygen microenvironment and cardiovascular remodeling: Role of dual L/N.type Ca2+ channel blocker
Shrilaxmi Bagali, Savitri M Nerune, R Chandramouli Reddy, Saeed M Yendigeri, Bheemshetty S Patil, Akram A Naikwadi, Raghavendra V Kulkarni, Kusal K Das
September-October 2020, 52(5):383-391
DOI:10.4103/ijp.IJP_136_20  
  966 55 -
CLINICAL RESEARCH ARTICLES
Presence of allele CYP3A4*16 does not have any bearing on carbamazepine-induced adverse drug reactions in North Indian people with epilepsy
Vivek Kumar Garg, Manoj Kumar Goyal, Madhu Khullar, Biman Saikia, Bikash Medhi, Ajay Prakash, Nandita Prabhat, Naresh Tandyala, Karthik Vinay Mahesh, Parampreet S Kharbanda, Sudesh Prabhakar, Manish Modi, Vivek Lal, Ritu Shree, Julie Sachdeva
September-October 2020, 52(5):378-382
DOI:10.4103/ijp.IJP_549_20  
  942 39 -
Outcome of hepatitis C patients in a community with predominant genotype 3 with standard-of-care treatment before and after advent of direct-acting antivirals: A retrospective-cum-prospective study
Showkat Ahmad Kadla, Mohamad Amin Dar, Nisar Ahmad Shah, Bilal Ahmad Khan, Asif Iqbal Shah, Rupakshi Pathania, Shagufta Parveen
September-October 2020, 52(5):372-377
DOI:10.4103/ijp.IJP_516_18  
  934 28 -
LETTER TO THE EDITOR
Are multiple sclerosis therapies safe in severe acute respiratory syndrome coronavirus 2 times?
Francesco Ferrara, Raffaele La Porta, Priscilla Santilli, Vilma D'Aiuto, Antonio Vitiello
September-October 2020, 52(5):441-442
DOI:10.4103/ijp.IJP_417_20  
  622 23 -
DRUG WATCH
Photodermatitis in a woman with infiltrating intraductal breast carcinoma: An uncommon adverse cutaneous drug reaction of paclitaxel revisited
Vikram K Mahajan, Vikas Sharma, Dhaarna Wadhwa
September-October 2020, 52(5):430-434
DOI:10.4103/ijp.IJP_337_17  
  498 56 -
LETTER TO THE EDITOR
Chlorambucil-induced psoriasis: A rare entity
Sumir Kumar, Priya Kapoor, Meenakshi Batrani
September-October 2020, 52(5):437-438
DOI:10.4103/ijp.IJP_452_20  
  436 18 -
BOOK REVIEW
Fundamentals of experimental pharmacology
Kanwaljit Chopra
September-October 2020, 52(5):443-443
DOI:10.4103/ijp.ijp_1113_20  
  354 80 -
LETTER TO THE EDITOR
Changing drug regimen during COVID-19 pandemic lockdown: An experience from a Tertiary Eye Care Hospital as a cornea specialist
Bharat Gurnani, Kirandeep Kaur
September-October 2020, 52(5):435-436
DOI:10.4103/ijp.IJP_688_20  
  394 31 -
Drug-induced immune-mediated thrombocytopenia
Harpreet Singh, Deba Prasad Dhibar, Deepak Chaudhary
September-October 2020, 52(5):439-440
DOI:10.4103/ijp.IJP_365_20  
  328 27 -
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow